These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12429069)

  • 21. Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening.
    Strauss GM; Gleason RE; Sugarbaker DJ
    Chest; 1995 Jun; 107(6 Suppl):270S-279S. PubMed ID: 7781405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung.
    Schiller JH; Storer B; Dreicer R; Rosenquist D; Frontiera M; Carbone PP
    J Natl Cancer Inst; 1989 Nov; 81(22):1739-43. PubMed ID: 2553993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.
    Rossi A; Chiodini P; Sun JM; O'Brien ME; von Plessen C; Barata F; Park K; Popat S; Bergman B; Parente B; Gallo C; Gridelli C; Perrone F; Di Maio M
    Lancet Oncol; 2014 Oct; 15(11):1254-62. PubMed ID: 25232001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
    Gebbia V; Gridelli C; Verusio C; Frontini L; Aitini E; Daniele B; Gamucci T; Mancuso G; Di Maio M; Gallo C; Perrone F; Morabito A
    Lung Cancer; 2009 Feb; 63(2):251-8. PubMed ID: 18632181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
    Karrison TG; Maitland ML; Stadler WM; Ratain MJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1455-61. PubMed ID: 17895472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-cause mortality in randomized trials of cancer screening.
    Black WC; Haggstrom DA; Welch HG
    J Natl Cancer Inst; 2002 Feb; 94(3):167-73. PubMed ID: 11830606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials.
    Oba MS; Teramukai S; Ohashi Y; Ogawa K; Maehara Y; Sakamoto J
    Gastric Cancer; 2016 Apr; 19(2):616-624. PubMed ID: 25804300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the bootstrap for estimation in group sequential designs: an application to a clinical trial for nasopharyngeal cancer.
    LeBlanc M; Crowley J
    Stat Med; 1999 Oct; 18(19):2635-44. PubMed ID: 10495461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for lung cancer: a systematic review and meta-analysis of controlled trials.
    Manser RL; Irving LB; Byrnes G; Abramson MJ; Stone CA; Campbell DA
    Thorax; 2003 Sep; 58(9):784-9. PubMed ID: 12947138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.
    Patz EF; Swensen SJ; Herndon JE
    J Clin Oncol; 2004 Jun; 22(11):2202-6. PubMed ID: 15169809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of screening for lung cancer with low-dose spiral computed tomography.
    Jett JR
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4988s-4992s. PubMed ID: 16000601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
    Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating treatment effects from a randomized clinical trial in the presence of a secondary treatment.
    Zhang M; Wang Y
    Biostatistics; 2012 Sep; 13(4):625-36. PubMed ID: 22510495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
    Mascaux C; Paesmans M; Berghmans T; Branle F; Lafitte JJ; Lemaitre F; Meert AP; Vermylen P; Sculier JP;
    Lung Cancer; 2000 Oct; 30(1):23-36. PubMed ID: 11008007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group.
    Ward LC; Fielding JW; Dunn JA; Kelly KA
    Br J Cancer; 1992 Nov; 66(5):943-50. PubMed ID: 1419641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.
    Qian W; Parmar MK; Sambrook RJ; Fayers PM; Girling DJ; Stephens RJ
    Stat Med; 2000 Oct; 19(19):2657-74. PubMed ID: 10986540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A re-analysis of a randomized clinical trial for gastric cancer using interval censoring.
    Sakamoto J; Teramukai S; Nakazato H; Ohashi Y
    Jpn J Clin Oncol; 1997 Dec; 27(6):445-6. PubMed ID: 9438012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.
    Panzini I; Gianni L; Fattori PP; Tassinari D; Imola M; Fabbri P; Arcangeli V; Drudi G; Canuti D; Fochessati F; Ravaioli A
    Tumori; 2002; 88(1):21-7. PubMed ID: 12004845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT screening for lung cancer: not ready for routine practice.
    Patz EF; Black WC; Goodman PC
    Radiology; 2001 Dec; 221(3):587-91; discussion 598-9. PubMed ID: 11719648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does clinical experience with a treatment regimen affect survival of lung cancer patients? An analysis based on consecutive randomized trials of the Medical Research Council in small cell and non-small cell tumours. Medical Research Council Lung Cancer Working Party.
    Wheeler JG; Machin D; Campbell MJ; Stephens RJ; Bleehen NM; Girling DJ
    Clin Oncol (R Coll Radiol); 1994; 6(2):81-90. PubMed ID: 8018578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.